-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AZhhcHqs22ExOK00u6zvAhWsQKx62o24RdK9yh3PoleD4TcuFD/E17L0tl+YjOXr BUV1oE8RIrc2QBSDwFyHyQ== 0001193125-05-002710.txt : 20050107 0001193125-05-002710.hdr.sgml : 20050107 20050107061322 ACCESSION NUMBER: 0001193125-05-002710 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20050107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050107 DATE AS OF CHANGE: 20050107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WELLPOINT INC CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 05516916 BUSINESS ADDRESS: STREET 1: 120 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 3174886000 MAIL ADDRESS: STREET 1: 120 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: ANTHEM INC DATE OF NAME CHANGE: 20010730 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 7, 2005

 

WELLPOINT, INC.

(Exact name of registrant as specified in its charter)

 

Indiana   001-16751   35-2145715
(State or other
jurisdiction of
incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

120 Monument Circle

Indianapolis, IN 46204

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (317) 488-6000

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Section 2—Financial Information.

 

Item 2.02—Results of Operations and Financial Condition.

 

On January 7, 2005 WellPoint, Inc. issued a press release announcing updated earnings guidance for 2004 and 2005. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

 

All of the information furnished in this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.

 

Section 9—Financial Statements and Exhibits.

 

Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibits.

 

  (c) Exhibits.

 

The following exhibits are being filed herewith:

 

Exhibit No.

 

Exhibit


99.1   Press Release dated January 7, 2005 announcing updated earnings guidance for 2004 and 2005.

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 7, 2005

 

WELLPOINT, INC.

By: 

 

/s/ David C. Colby

   

Name: 

 

David C. Colby

   

Title:

 

Executive Vice President and

Chief Financial and Accounting Officer

 


 

EXHIBIT INDEX

 

Exhibit No.

 

Exhibit


99.1   Press Release dated January 7, 2005 announcing updated earnings guidance for 2004 and 2005.

 

EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

LOGO

 

LOGO

 

WELLPOINT UPDATES EARNINGS OUTLOOK FOR 2004 AND 2005

 

Indianapolis, IN – January 7, 2005 – WellPoint, Inc. (NYSE: WLP) today announced updated earnings guidance for 2004 and 2005.

 

Net income for the fourth quarter of 2004 is expected to be approximately $0.90 per diluted share. This estimate includes:

 

  A loss of $0.47 per diluted share due to the successful repurchase of surplus notes in December of 2004

 

  Expenses of $0.31 per diluted share for merger-related undertakings in California and Georgia

 

The estimate of $0.90 per diluted share differs from previous expectations of $0.95 to $1.00 per diluted share due to the successful repurchase of 9.125% and 9.000% surplus notes. The tender offer attracted more investors than projected, resulting in the repurchase of 86.6% of the notes available, as compared to the 75.0% previously forecasted. This generated a pre-tax loss of approximately $146 million, which was greater than the $125 million pre-tax loss previously anticipated. The refinancing of these notes will result in lower interest rates over the next 23 years.

 

Net income for full year 2004 is expected to be approximately $6.07 per diluted share. This estimate includes:

 

  A loss of $0.61 per diluted share due to the surplus note repurchase

 

  Expenses of $0.39 per diluted share for the merger-related undertakings

 

  Tax benefits of $0.29 per diluted share associated with a change in Indiana laws governing the state’s high-risk health insurance pool, which was recognized in the first quarter of 2004

 

  Net realized investment gains of $0.16 per diluted share

 

Net income for full year 2005 is expected to be approximately $7.75 per diluted share, consistent with prior guidance.


Management will review the updated financial outlook in detail and also provide 2005 quarterly earnings expectations during a conference call today at 8:30 a.m. Eastern Standard Time (EST). The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers:

 

888-423-3268 (Domestic)

   800-475-6701 (Domestic Replay)

651-291-5254 (International)

   320-365-3844 (International Replay)

 

An access code is not required for today’s conference call. The access code for the replay is 762260. The replay will be available from 1:45 p.m. EST today until the end of the day on January 21, 2005. The call will also be available through a live webcast on the internet at www.wellpoint.com under Investor Info. A webcast replay will be available following the call.

 

#         #         #

 

Contacts:

 

Investor Relations

Tami Durle, 317-488-6390

 

Media

James Kappel, 317-488-6400

 

About WellPoint, Inc.

 

WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through HealthLink and UniCare. Additional information about WellPoint is available at www.wellpoint.com.

 

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

 

This press release contains certain forward-looking information about WellPoint, Inc. that is intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of WellPoint, Inc., that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in public filings with the U.S. Securities and Exchange Commission (“SEC”) made by WellPoint, Inc. (fka Anthem, Inc.) (“WellPoint”) and WellPoint Health Networks Inc. (“WellPoint Health”); trends in health care costs and utilization rates; our ability to secure sufficient premium rate increases; competitor pricing below market trends of increasing costs; increased government regulation of health benefits and managed care; significant acquisitions or divestitures by major competitors; introduction and utilization of new prescription drugs and technology; a downgrade in our financial strength ratings; litigation targeted at health benefits companies; our ability to contract with providers consistent with past practice; our ability to achieve expected synergies and operating efficiencies in the WellPoint Health merger within the expected time-frames or at all and to successfully integrate our operations; such integration may


be more difficult, time-consuming or costly than expected; revenues following the transaction may be lower than expected; operating costs, customer loss and business disruption, including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers, may be greater than expected following the transaction; our ability to meet expectations regarding the timing, completion and accounting and tax treatments of the transaction and the value of the transaction consideration; future bio-terrorist activity or other potential public health epidemics; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. WellPoint, Inc. does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in WellPoint’s and WellPoint Health’s various SEC reports, including but not limited to WellPoint’s Annual Report on Form 10-K for the year ended December 31, 2003, WellPoint Health’s Annual Report on form 10-K for the year ended December 31, 2003 as amended by Amendment No. 1 on Form 10-K/A, and WellPoint’s and WellPoint Health’s Quarterly Reports on Form 10-Q for the reporting periods of 2004.

GRAPHIC 3 g98029img1.jpg GRAPHIC begin 644 g98029img1.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`)0*Q`P$1``(1`0,1`?_$`+8``0`"`P$!```````` M```````("04&!PH$`0$!``(#`0$`````````````!@0%`P<(`@D0```%`P$' M`P(#!`8)!0````,$!08'``$""!,65I97F-@2U0D1%"$B%3&T=1@U-A?76!DR M0B0TU"5VMSFV=YO7>47,TYQS.SS&]:M7M9#>FY6E*01(`* M(`&CX1M6W4N('7SXUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^ M;G/[M3V[R3Y:WU';#UUF_P`>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N- M8V0VZEQ`Z^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1V MP]=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4 M]N\D^6M]1VP]=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ M`Z^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\` M'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M M]1VP]=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[ MM3V[R3Y:WU';#UUF_P`>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0V MZEQ`Z^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9 MO\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4]N\D M^6M]1VP]=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^; MG/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\`'N-8 MV0VZEQ`Z^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP M]=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[ MR3Y:WU';#UUF_P`>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ` MZ^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>X MUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4]N\D^6M] M1VP]=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\`'N-8V0VZ MEQ`Z^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O M\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y: MWU';#UUF_P`>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G M/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9# M;J7$#KYN<_NU/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4]N\D^6M]1VP] M=9O\>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R M3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\`'N-8V0VZEQ`Z M^;G/[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XU MC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU'; M#UUF_P`>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3 MV[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9#;J7$ M#KYN<_NU/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\ M>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:W MU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\`'N-8V0VZEQ`Z^;G/ M[M3V[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9#; MJ7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU';#UUF M_P`>XUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3 MY:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9#;J7$#KYN M<_NU/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC M9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU';# MUUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\`'N-8V0VZEQ`Z^;G/[M3V M[R3Y:WU';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9#;J7$# MKYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU';#UUF_P`> MXUC9#;J7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU M';#UUF_Q[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9#;J7$#KYN<_NU M/;O)/EK?4=L/76;_`![C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\>XUC9#;J M7$#KYN<_NU/;O)/EK?4=L/76;_'N-8V0VZEQ`Z^;G/[M3V[R3Y:WU';#UUF_ MQ[C6-D-NI<0.OFYS^[4]N\D^6M]1VP]=9O\`'N-8V1CU0,FT;:XK4KM8KGCG^ MH;1_@";^[85[GR-_AUL_14OP"/&^+K<:%IKL*+-F[-$"K2J*49(2N9*:@'_-+H$=@UF&4;5; M6%:YT7M5VZ:BJ33JH2D34I,@%()_Y?G'`=9FDC3&C:58*UUZ+7#,UH3EB3GQ M"#[C#4`,SE&0HLEQII)9T%T]+<[(3T9'=S/7FZ,,.5&N4P,E000?N!,QS`@) M;:9>OMYJ7MSEG,*&_P"XT***R*E#&$5*2B4S*5DE"TJD")R))D)`$ZV^6:TH ML[?,-B57_(5JRZ2Z=;"5TZB1BD%(`"DE,R#*8D)F9(%>$/-5,?4N18R%O(U@ MC/*1F0U5?(B+@`=Q3'"YDQ(/Y$QQ`APP35BIS/9YY89VQS^E[XWM^%5C^NML MPKN::=.BQI?UI.L2&)0=$;*+O3=64;)V"WNLL#I1E9)(1K3F/D5^ZQ`N)@6$.7^ ME[VQN+_K5!66KGR\V=O=J;VW(#BBFH$EM4,L0G(J%?3+YR_E%K=J62[3=:]L M6T?K-"LI!4'"!/"93`['_A/^<10^1[1_&^E&0856H*>;T?&GO5!IXCW4O"RA M)9!)3I,06H^Q%8D*S)""0@"**==3?/(N60IP@5+D#()D+8VROAGE6\RC?WE\ M:N*=SITZ=U9.ZC>L*9)IJ4B1QT\4R$J!T!1*@09_"--FBR-;.YH5+?4J5+:[ M;(KTBL`5`EU[4[6VO686UK>8@VK*4%83)6A"E:"0?B!\(D! M_:/\('^&'Y"^XR%_[JJU7Y/F/XVU?_/5[V-E^:R#X2Y_^:EW<56O$=JF749'=TU/!1 M9D?HQ)<NF[^U71]/\&L\O(J-%&H":H_?T;3X MU"Z\CHSA;$=NU12&,Z@)?3BBGD>)HX8)[-4#"R"+@YWV@I;";NLYVBYMF]W[ M!_:W-3LS5H45HJ4%824JJ)!6GLB1A*YC#.9/0#F5V^4KI;W%>U]LRN3=&,4Z MU5"T5DS`4E"B$*[0`S"9'%T`=)%1%7D1<7&L6`]#.F'29IPU):RV!/\`J'?& MKH"2G'&$<1"_4"(XV83!C-\'([/CO5_'&\ZUQP/]:7$\0V`13P@RQ(CEC@:M MB-EC?+K]S=,RWF^N[1EZJU:-F!IIJ5*J%5:BUU$"H,"`I(2@`R*E&95]W1%N MWMV7[39FMTOE-RYT8IL:PAJ M'T5R:Z,VG+!IY-N0--LSNU@+<]P4\F:*G8A'SV+1$3S+DB]]ESHPJ(KYIA>V M/VF00XES.>8`&UR\_P`PK>.;3F*BCMZ`0I#BDE8H5D+GH&*>&HB0"TXCTS`E MI.MOC*Q):M[G8JJ^QK%25T*JD&M24F6DX98J:YG"K".B1,]`KQJKB:A2$*0A M2$6[P!!^B)J?'-_.7J?C2>I6=2QK7=6F1&;T2S*UXI2TUOH\%L*5"2R>NX(M MD,0^?_45H\!GZ,@<<@\POI:UP\O7!W2Y9CKYM]/V:LUH4$VY+@JJTE525&LN MF0,-2G(2`/Q^/ST6EM86"CEC]\NU)Q6K*?JH!-.JFF`!214!,Z:YF9(^'P^4 M;:B:8]!>L/33JND?2*WM2T%3EI&C(*=5MB3-(C%E^.),B)-5@$IY_I;G;L')=CYEM9 M"#AF>')&1($-)=#!7#N.9]$+DL\KV,B6N/@+E^6V>../7%2XYQN69+E:[+68 MT6;%5`#M:2UJ5VM%-0Z4K2-!G\.B47U-AE2WY?M]QNU)Y5=O$UB>RJ(2D=E6 M53&A2"=(E\>F<06U1NC0&OH#6!T>1-J6CIREUQ7ZDJ*'D2MB0*H M11I,]M&""B$?^N8@@V8N&07Y;8VO^-4MEH9HI55F_P!=G6HE(P"C36@@STE1 M4M4Q+Y2B>N];+E2F@62BZI50HXC5J(6"):)!*4R,_G$+:HHT43U^3[39'FD# M7AJ(TWQ0.XS$>Q8R9=W=^RRTN[X(#NNA15A!"9A:DZ`22-`'QBBS9:VUES"YM;/ M$6U%20G$9JTH2K20!\2?A$"JIXG8MUT>P)HB_D=F[5[J]9\_OW<+49&T'MMM MP?(;18@VQ?;%]0=_N>8_4C:PV& MHUI=JTJ5E*K4U+^XM*9#"I,IXHM+);K!Z?<7J](YKDE::8Q=K!3=DY$<=Q?KS?;T?HBPH M?>-0(\7*[$T%LCHH(F?JPPRPRS[8VSK3?(7=W5OJ6\3QII4:B5GZ3APJ4L@2 M5A)F#,`CIC"N-?*"V:TVMN^IOC+"JI5IJ0/J&*82@$S3,"1Z9&*YZK8F(N3^ M*#09I]U3EY:DO5X[WE'T'MQUP?I[8*XT%1-03JQJ,U'R(F--EXB**XC*J4?; M3#;@!]77BU\RF897,N)<ZV0T&=AITZMR6BM76%`J`H-Z94O0 M""%+5A2@Z=,Q(_"XR=EVVW<5G5Z6NE;TKI44%)`)K5UA*=)!!2A,U+&C1(S$ M5;S-$[O@B7),A9_D`F-[XY6O>UM[ZAC44A7\4D@_RT3'S$9_3;"BMJ2U!PEI]05E.;BQ-4IL6+T]P*V&0J:A&'LY M$YOXK)PO@*`,<`3+'[CW+AYV%,>C9A_GRQKBN]QIVBU.;K525TV]!=0I'2K` MDJD/E.4I]`Z3HCEM;!=TN3>VTU!*Z]9%,$]`QJ"9GYRG.72>@1;2MMOX3&M- MJGI.=D7ZZ6W=N/\`/Q&XM6:G*D;$%5*=R8MCM!0>RI!9ID712,WIR-6N'E"TZW,:M;A?*%:V+QTA52U%.H04D8@@5@N9J%.@'#@*O^ MG3%E4I9#HOS9JU*X)PU#34X-1`(4#A*C2PR"`=)$\6'[8J)GZ,D>&)LE.*6[ M(K-EYN,%\N)LMR4H]64A?9DA-Y-41@D)X-]40E1:2A22^E;$SL@C9C[;,3(' M+/+,/*]7EK>5+A;J#ZK1J4*M6DE2J:P4KIJ(^I"@H`S29C2!/IEIB+N+1#%_ M69TJM.O2IU%)34004K2#H4""1(B1Z3+H^$3>^-G3SIHF@KK!D#5,D2JXH^TR MZ9SLW%V]$#M0F:Z5M4*2&R&GG^,1,BOS_`(]OQ!>.?ZAM'^`) MO[MA7N?(W^'6S]%2_`(\;YR_RNX?JZGXC&ZU51-0I"%(0I"%(0I"%(0I"%(0 MI"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"/2GJ5G[1]$NE+XKT747H%;^ MK1T*6A=&5$-Z*^I.6Y.*6:X2#%JB31U4+%0+C&_O#&-S/U,7#^OH MPPKJ"SVN_OKY>ZEINBV-$7(@H#>C6Q*[*F<6*H"1HD)#1HGTF.T[K<;(RL]H MIW.W)>53;P0HUZM+".TJ?3*F0#IF9G3IE%4^L/7FIZGV3$L(L*%(TTPZ9X+, M.=3C>#HK%<*F2NYGB,!FX'P_GBZU%1<<@OQ+6RQ##QR%&S$M M[!EA%F$=)Z3H$H^]YB7=J%%@WH4F MEJ;E112IXB,2OO+6I1*EK,I3/0/XF<;M-?\`]C(!_P#>N*__`%TA5M[O_:77 MZ>I^!4:NU?W1M^HI_C$>E#4/KVT,-7Y4]0T6ZL/CDTNN"/"&I&0F8\9\((CY M5Y-*'\7,<3P)5>+=47>;;3U+E%#T'%E-*EB.9HKM?M_J);``3J"TY8S+7R2T M>V.[O4.RS0M%`E`ID80>S0H("D3&A"B52,IZ-([2N>8LOTS[-(F$IZ=`)DK%I5TG)?`W_Y;=&'_`%J]O^T,AU\D_:?MB-4K$HJD!,SD.@?8/LBTSX]!M;<)Q7J5UKZ, MG^B8@07@PV7/L.W;X[_4W=%TEC+EPG,ZXT5VJLL]PQLBGV\*&<.YCV/I668@ MV'VX7K'O%9K&7+B]9Y=S#25-SC70JXL`34IX?I34"@M-0A0D)85:!I,A%=EH MWY@S=7ZQU$R;X$UJ4L9537/ZE4RDI4@$:3.:=)T#3$QXODN!?E1B[5@AR]H7 M@73_`#!!6EV7-1:!JUTH-I7AUII;CC-%#64=N39'A<\KLI6)R>=!S(9'_7]] MD:S])(MB+GD*'/O6=SR2]8U6%S=.F#E[2H*:N5"JHIJ&151J2"P:8^K#T2^\ MJ6@[MHZMV;VCRF]M[=L];M*E8.&Z322%4Q,)JHF4$5#HGTS^Z)Z1YX:[7CK2 M+SV;J"UW?'%I-TWF312`-5.AS5(UU>4V?&CFRZXNUMS/7RL]>JN# M1#--=-183VM(FI@[*HI.A14/K25?40#H`E/AOU"UW#+M',C1H&+I3M5%5-!/ M950$8^UIA7W0D_0H)^F9'29RI9KL2(6%(0I"%(1Z#=-T^LO3W\(I5S/;35"> MIU/6OE2D!"*-*QNPPI@H$<%&UMN8 M5+1GFBSS;7C19TDJ2E]0II^LBV74E"PJO.=K\I+ZX,^S6S$FU5-,*FU1I7BIKF1+1*4IF.SZUZ3: MQ^U^V^_-^K:;7'9WMDL:K+VN)\_> M=KA_]FHFI@PXON84(EBQ?5.<\*>B6F*N]Y3=NSPLV33L\7_KTU(QXL/WYK7/ M#+Z92E-73/1$6M]&EBW7YY/_`"VZS_\`K5D_]H8\J#Y9?X+;OZ:_]VI%IS#_ M`,S??U$_[:(J*J\B+B_;1+/173G\0>J20#<%:?\`4,$-KH@5O;A:DV.L2!'@ M.:E$,B&K.`!"1'6SCN#C3K)UPBQBYN^`81@:UP\KYVOCU?F.V*NV?635+ETT M(MM=6-NL(J:*M,8<12L83/2)=(&F.QK#<1;,E.W*F[9R/W"BG!705HTTUZ9! M23B$M!G\3HB!.HK7JEZ@XU-1R4T*_']`(QE725:TAZ=8/>##DHMBE"B"Y)15 MP+4K.XB&D*GK])L*Y/+(7#&UK9X_3ZU3VG+"[4\#M5SNCH!)'9UZR%T]/Q*1 M229CX&>B)RYYB1F6(V(^%LK8WZ=MM?,%XS-;3VFGY+X'5%9TQCK`CXPS9%<:LU2;.6,]14!9@1^]%1T-5*5 MUU+9JD^VZ0('2Z?@:,6%N3-&M3T%P_'$C-^(Y#?DD-Q&8&V9JMK5\Y2O`K%2[-S.D MS7/J&T_1,J*BI';`=")NO9<.%U%=0R;J9;9>H[,7#Q7ZA&UM@GW(*AF\_KEG MD83\[YY99^K*];D^[.[[EII=7R4I=U4'%A$DJ*5J1C2#T!82%C[%1,9JMC6S M9@54@3:^K(((X7ROGCC?U_A]+SO,!H7SFRM! M5K4#4N8':4E!-1/^C5TH40H`_;(QOLCN0S;W9T:=*L$6XG!4!4A7^K3T*`() M'\Q$?Y.^2Q'DN/'I'X/QP?&)'`KQ;BHW@W[&.G5]MV0VAFJ%1"N+@9:Z?FI: M))#C3+B;4J8%*&<`Q<;7N'E:WTK:LLGU&;NFZ-WO-84UA6"I70JFN1GA6D40 M2D_$`C1\8UCO-2'3:HV%KM-(K24XZ=%:5IG\4DU2`H?`R/\`"*Q*LHE(4A"D M(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D(Q2Y_ M0BQ_"U#]T&K77C^TNOTU7\"HSK7_`'-M_7I_C$3(K\_X]OQ!>.?ZAM'^`)O[ MMA7N?(W^'6S]%2_`(\;YR_RNX?JZGXC&ZU51-0I"%(0I"%(0I"%(0I"%(0I" M%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I".HR'-4H2NAQ>VY"=IQRHD+L4& M,XP(&B:65#:3&+K"HO@M\H(G$"8YPO@L+1H?:&LAQ_4->UQ/3;&UL)I;F3&I M6K-*814<5>TJ&9.)<@G$9DRT`#1(:.B,MR_=O*=&DY65TZ%/!3$A]*)DX1(" M>DDZ9G3'+JS8Q(R[?7E=JKZ&Z&^=S35YMJZ:O(BB%@"*(05T;E-ER!0TNN);-"'513'* MI94BG%Q39H7+.^`((0=KW_+C:WX5Q,F;:WM*;%F@(:4D!*$B9"4@2`TDG0/F M8Y7;MP^C$@!$5&U M#Z4M)Z&,>8[;5QRI@XW4]R!I83H-H(>9('$L3-G3!8F$#@&7P"#PQQMC,[1; M6#MP^9TA3O),0_W M>5(>V61?+J?'5[R*GW#SGXZIPT^I%8DG28^9FD-Z2O)K@,.N0I#<:H[7FY39 M<@4-+KB6S0AU44QRJ65(IQ<4V:%RSO@""$':]_RXVM^%6;)FVM[2FQ9H"&E) M`2A(F0E($@-))T#YF)-V[K#&]L:ZV>UWQK^2NU"G7;3G)0G(_-)Z4GX3209?&,BVW6XV=S^;ME9=%Q M*4TGI'R(Z%#[""(D?J)^4[7UJLC\Q%,X:B5QQ1LH'P51:9#8:$;18VW,H%AP M#1D`_`17[53$W$W=,OR0:W-'C<5&7IYU`.9DL99."J"@P55&9TBQ^*H#XWL84 M`6))S;>31)GS5[8Y"C`$@Q16IB8'-*JRW2`Z6V"RH&D(K9::<:R+YG"319+534%F-,N>R)@;?% M.3RUA]@%M/5L@_3F6;+]FR_04WL[=%"FLS5*94HCH*EJ*EJE,RQ*,IF728Q; MM>[K?*R:]UKKK+2))G()2/B$H2`E,Y">$"AKB,\H_ M<]@,5YIN5NN=+6D!92%*Q?#UAF"PE[?2_IOC];_7BN5HMMX13IW&D*HI54U$ M&9!0M/W5)4DA0(^PQRV^Z/[4NHMA4-,U:9IKT`A2%=*5)4""#]HCAU;*-?%C M$#_+7\B6F2*6K!\%:FW1'L5LG]Q.KS-558;]0<: M^<-9;4P)Z7R[E]\+Y M8X98Y%FR?EO+[I3VSM44'2J905!2S-)*5$?4HCI2D]$]$<%VS5F"^-TM+JY5 M6;I6%A)2@24`4@_2D'H41TRTQ!:J6)^+=?\`/D^6W_&>]>28A_N\J#]LLB^7 M4^.KWD6GN'G/QU3AI]2*N)!?KNE1^O>3W^M#N1^2.[W*_7LXC(!,L97G<\%D MZX7(M&"R>7)D"XZHLJ(P^>``00.&0E[888XVMC:T:M:#)K39-4A#6C32A"1/ MZ4H`2D:9G0`!I),2+EQ6>.*CMRK$XJK4M2M&E2B5*.B0TDDZ!*)2:7/D0UG: M+$!TM?3!.B]$J"]53.C".ELKI@',`GE<.V(68>%[ M?C>U[_C6EO65,O9BJHK7ELFO5II*4DJ6)`F9'TJ3\?G&WM&9K[8J:Z-I<*HT MZB@5`!)F0)`_4D_".NRY\Q7R4SO&KPB"6M5#K><;O]($07>UCK3C,D46T@84 M(<0D.;2&2G*0&&0H&%_4".'G^7]M8##(&4+8\IOV+)%-W25B0H*J$@_.161K M$9KW.^:;BU6R>/%U&M1,E)*4"8^6A(.HQ6P3-#$394Z7V7W!,P`:`VYH,7#,/.WX98WM>]JL%)"DE)Z")?+_`(C2/Y1+))2H M*'2#_'_]CJ$XSG+.I.4'/-$XO52D.3WEDDW.IATFI)IPTGJ*>:+GB!\B8%*'2)TH+@8*G"9HOF& M.6-%AP\U[5GJ2E:2A8!01(@Z00>D$?$&,)*E(4%H)"@9@C M001\1%IJ;\WORGI34`:!?5X[S!0HD9(1-QJS*B=>DHDF9@8%LP24NKC`495) MCY!8?B.$LX#WSSSS]?KSSRRBE\N,DKKFN6%,**L12%U4TR?MI!8IG^&"6J*Y M&?LW(HBB'JR`F044TRL#[*A0:@_CBG%7BXN+3F6EAR.185'"XG"J*"XOKZXH M&U9:7%I6-C'U586%4^,8/*2HI'C`@Q@P,)F*,+GEGGE?*][WM*=.G1IIHT4I M120D!*0```!(``:``-``T`1)U*E2K455JJ*JJB223,DG222=)).DD],2#TOZ MQ=2FC!W.!]Z8Y45HG=KI;EVDOK*0DME7'4F[DID%FZ8*`Z$1=*!!74TP`7UA MAX"?4.UO5Z;WM?57FP6?,-!#:\T$UZ"%XD@E0DJ1$_I*3T$B-E:;W=;%64XM M-95&LM.$D!)FF8,OJ!'2!$TE#YU?EB52!Y+4-9#T,D%(F9('2^3*B3'$P4.` MYES(.60U[?7\+VO4ZCEID="@M%OIA0,Q]=7I'_?&]5S!S MBM)0I]4*2)'Z:?0?^R*EJNHC84A"D(4A"D(4A"D(4A"D(4A"D(4A"D(4A"D( M4A"D(4A"D(4A"D(4A"D(4A"D(Q2Y_0BQ_"U#]T&K77C^TNOTU7\"HSK7_G^,1,BOS_CV_$660WHILT&W9+EV0LD[]'(_97/Z=&W@=N6V&&RN:Q+ZI,P M,1_3_I6PO?'Z_LKUIE)7,(998?MZ+,6/Y6GV?:+&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_' M'5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0T MQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[ M\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E M#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX M;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^ M[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA M>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W M7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=N MR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WM MV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_> MN!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W M+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU; M>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[ M]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7, M[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_'' M5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ M7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\ M<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E# M3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX; MOQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[ MAAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA> M4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7 MAN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR M%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV M[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N M!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+ M#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;> MW;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[] MZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[ M&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5 MM[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ< MSMRP\;ONX8>7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\< M=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ M7>_>N!MUX;OQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3 M%S.W+#QN^[AAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;O MQQU;>W;LA>4-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[A MAY=[]ZX&W7AN_''5M[=NR%Y0TQ7>_>N!MUX;OQQU;>W;LA>4 M-,7,[&[\<=6WMV[(7E#3%S.W+#QN^[AAY=[]ZX&W7A MN_''5M[=NR%Y0TQ7>_>N!MUXQZLWXR_2E/[B7'W8O^GG=O<' M3JW[C6!^V$VMPK9ZHK87$]'U]/UO:WU_;6%G('Y^AV*[QVO;(PS0VE/$)3DN'1H< M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T- M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,O_``!$(`#D`V0,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0`` M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$% M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U M-CH.$A8:'B(F* MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G: MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(# M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q M$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8 MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?J***`"BBB@`HHHH`****`"BBD M.=IVXSVS0`M%<'WC[Q/K>4\/>&Y% M4\":=2P'\E_4UFZL3THY3BGK*/*N[:2/3"0`23@#O7/ZIXW\.Z066YU.%I!_ MRSA/F-^G3\:XJY\*>)=4C-QXL\31V5KU,2R#`_`87^=9_P!H^'7AT[8+>?6[ MH="WS)G\<+^AJ)5)>GJ=5#+*#=N9U'V@M/\`P)Z&_)\6K>:4II>AWU[[_=_0 M`UUGAKQ#'XBL'G^RS6D\3[)K>889#U'X$5Q%OXE\9:J@C\/>&X=/M3]V1X\# M'U.!^E6(8/'FE72:CJ&JZ=(N1YMJSJK2*#T!V@9Y..:49RO?=>AIB,#0Y.2* MC"7G.[^:2L>DT5'#-%<1++#(LB-T92"/TJ2N@^?:MHPHHHH`****`"BBB@`H MHHH`*6DI:`$HHHH`****`"BBB@`HHHH`****`.=\46>JF"*]T*"UEO8F^>*= M%(E4CU/<8&.?6N4#?$O6XQY;V6GV[?\`+2-EZ>Q&XUZ;7":M\-(M0U&>XM]: MO;."=S(]LG*!CR<7PQ^Y' MG(M?B1XD.9KB/1[9OX5.Q@/H,M^9%6;;X264C>9J^JWE[*>6P=HS]3DUZ-15 M^RCUU.%YM72M12@O[JM^.Y@^'/"UOX7,\-A<3-9S8;R96W;''4@^XQQ[5O44 M5HDDK(X*M6=6;G-W;"BBBF9A1110`4444`%%%%`!2TE+0!QWQ`U;Q#X>T236 M=&:TEBMP//MYX2QVDX+A@PZ9'&*I>&==\1^*/`O]LV5]I_\`:+%MMN;4^6K+ MD%"=^E=K?V4.I:?)?#'76\&WOB?0-1)_T,//& MAZLZ?*0/=OEQ7722G2=E[R_(RD[2UV9U'PV\;:]XRO[V/4)K*U^PE=]M%;MO MD!R#R6XP1Z5L:_J?BBV\7Z=I&D76GO%?+)*WGVS%K:-,98D,-V2<#IS7G.E1 MWO@#XN6+:C)\FLQ`W#=%#RGYA_P&0?E7J_AY!J6L:IX@;E)7^QVA_P"F,9() M'^\^X_0"JK1C"7/%+E:T%!MJSW)]<\26WA73H[G54NI854"6Y@M]R*>!D@'Y MF:S<6;@LLT5DS!@#@XQR>0:;\3`#\.-)`Y`6>.`O'N/; M(Z'CO6Q9V%K8&X^S1"/[1,T\@'=R`"?QP*X#XX?\D\;_`*^XOZUG3C"=51Z, MZ@\D5J5D^%O^11T;_KQA_]`%:U M9S24FD4MCD-5^(^BZ)JRZ7?P:C'>.0(HQ:LWFY.`5QUR:ZBSN?MEJD_D30;O M^6MUX5XB>XC_`&B+ M9[2%)IQY12.1]@;]UTW8./RJ\+%2]>D7+?8=+F>%1^XA8HO;Y5X'Z5-50Y8V^+K8<;W? M8R-4\::3IFJKI*?:+[5&&?L=E%YDBCU;LH^I%5Y_'>G:==0P:S:7^DB=ML%; ME(=6BOH1(2(I%MRR28QG!'UK+^#M_-?#UEXI\0Z7I5^I\J2S MNBKK]Z-P8\,/<5G24'.T]BI72T.KO]3CL=.^W"&>ZAP&_P!%3S&*XSN`'4?2 MJ?A[Q-9^)[3[7I\%V+4_=FFA**^#@[<\FO./`WB+4/!/B#_A!?$[_NMV-/NR M?E(/1HZ3J=OK.DVNI6F_P"SW,8DCWK@X/J*NU4TW3X-*T^&QM@1!"-J M`GH,YQ5NN=VOH:(2O.-3^';7_P`6K/Q#Y:_V<(Q-.,CF9.%&.X/RG_@->D45 M4*DH-N/703BGN>?_`!2\$W/B^PTYM/4?;+:X`+%@N(FX8Y/I@'\#7;V%E#IN MGV]E;KMAMXUC0>P&*LT4.I)P4'L@44GK:MX5N](TC3_M,UXFPR-,B M+&,@G.3D\#M61X3B\3^'/!]IHL_A4W,ENKJ6%]"$?+%NY]Z]#HJE5M#DMIOU M$XZW.4\*VGB&?4;[6/$T,5M,$Y)YKOJ*%5:FII;`XW5CB+.^\6Z;X6_B$995`R<'...E;GA73[W3]"B&J.'U.=C/>,#D>:QR0.V`,*,=A6W12E M4NK6L"5CROQ9H'B76/B%HVNV>B$VFF%^,\UV]%5[9Z72T]?\Q1WOAGQ==?%2'Q:N@J+:)TQ`;R/>5";<]<9[U['12IU73NTMQ MRCS$5O(\MNDDL+0NPRT;$$J?3(XIY`8$$9!X(-.HK(H\TTCPIK7@#Q#?7&AV MJZGH5\VY[02K'-`PZ%=W#`9(ZCC'I5OQ5'XG\8Z8VB:?I+Z79W!`NKR^E3<$ MSDJJ(23GUXKT"BMO;MR4FM>Y'(K6Z&5XW>O4J*4*LH3Y]V-Q35BIIT] MS<6:27=D]G-T:%I%?'XJ<&N3U"3Q-)XSL-0M_#A>PM(IH6+7<0=]Y7Y@,]!M M'!]:[>BIC/E;=AM7./\`'W@R+QGX>V!!#J<`\RUD)Y5NZ$CL>GY&M#P3I]YI M7@S2['48S'>0P[95+!L-DGJ.M=!13=23AR/87*KW*FH3W%O9O):V;7$TU.VU+2547D@E2:.X1U0@'AAG/ITKU&BB-1QBXVW!Q EN[G.Z-<>)Y+Y%U:SMH[7RSN:-AG?GCN>"*Z*BBID[N]AI6/_V3\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----